Nav: Home

Current Bisphosphonates News and Events

Current Bisphosphonates News and Events, Bisphosphonates News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 6 | 202 Results
Osteoporosis drugs linked to reduced risk of premature death
A large cohort study has revealed a common osteoporosis drug significantly decreases premature mortality risk, likely related to a reduction in bone loss. (2019-08-12)
IOF review of impact of drug holidays on bone health
The impact of interruption of anti-osteoporosis treatment in patients on therapy with bisphosphonates or denosumab is reviewed in a new IOF Working Group paper. (2019-07-08)
Study supports bisphosphonate use prior to denosumab to prevent loss of bone mineral density in post-menopausal women
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) finds the risk of bone mineral density (BMD) loss after denosumab discontinuation is associated with younger age, high bone turnover markers, and not receiving the bisphosphonate, zoledronate, prior to initiation of denosumab. (2019-06-13)
SWOG spotlights high-impact research at ASCO
At ASCO 2019, SWOG investigators will report on 16 group-led trials, one jointly-led study, and another 12 involving partners. (2019-05-22)
USC research shows remedy for painful jaw disease
USC researchers and collaborators report a breakthrough to prevent osteonecrosis of the jaw, a side effect suffered by some people undergoing treatment for cancer or osteoporosis. (2019-04-11)
Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society. (2019-03-25)
Bisphosphonates increasingly prescribed to the women most likely to benefit
In recent years, women who start taking bisphosphonates (BPs) to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report. (2019-03-23)
US older women three times as likely to be treated for osteoporosis as men
Older women in the US are three times as likely to be treated for osteoporosis as men of the same age, reveals research published online in the Journal of Investigative Medicine. (2019-02-14)
The delicate balance of treating growing but brittle bones
Turning off a bone receptor protein could potentially treat osteoporosis in children without affecting bone growth. (2019-02-01)
Sex-specific effects of DHEA on bone mineral density and body composition
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone (DHEA) may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M. (2018-12-04)
SWOG shares trio of studies at San Antonio breast cancer symposium
SWOG Cancer Research Network members will share the results of three studies at the San Antonio Breast Cancer Symposium, an international gathering of breast cancer physicians and researchers that starts today, with an estimated 7,500 attendees expected from more than 90 countries. (2018-12-04)
Failure to discontinue medications can contribute to inappropriate prescribing
The continuation of drugs that are not intended to be taken indefinitely is a substantial and common problem that could contribute to over-medication, particularly in the elderly. (2018-11-12)
Study: Denosumab effective in treating osteoporosis in transfusion dependent thalassemia
For patients with osteoporosis caused by transfusion-dependent thalassemia (TDT), a twice-yearly injection appears to improve spinal bone mineral density, according to a new study. (2018-10-31)
Study sheds light on atypical periprosthetic femoral fractures
Following surgery, some patients experience a broken bone around the implants of a total hip replacement--called a periprosthetic femoral fracture. (2018-10-03)
Patients 65 years of age or older with hip or spine fracture should be treated for osteoporosis
A coalition of the world's top bone health experts, physicians, specialists, and patient advocacy groups today released their clinical recommendations to tackle the public health crisis in the treatment of osteoporosis and the debilitating and often deadly hip and spine fractures caused by the disease. (2018-09-29)
Investigating what keeps metastatic breast cancer in check
New evidence suggests that inflammation may help prevent growth of tumor cells that have spread, with important implications for clinical trials. (2018-08-27)
Osteoporosis drug may benefit heart health
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. (2018-05-11)
Fifteen percent of osteoporosis patients who take 'drug holidays' suffer bone fractures
A Loyola Medicine study has found that 15.4 percent of patients who take so-called 'drug holidays' from osteoporosis drugs called bisphosphonates experienced bone fractures. (2018-05-04)
Exercise may be best intervention to prevent falls among elderly, according to new study published during Falls Prevention Month
Exercise alone or in combination with other assessments and interventions appears to be the most effective strategy for preventing falls causing injury among older people, a new study has found. (2017-11-07)
Women who discontinue bisphosphonates for two years or more have higher hip fracture risk
Women who took a drug holiday (temporary or permanent discontinuation of a medicine) from using bisphosphonates for more than two years have a significantly higher risk of a hip fracture compared to others who continued their treatment, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego. (2017-11-04)
Confusion about long-term treatment of osteoporosis clarified
Osteoporosis is a common disorder among postmenopausal women which results in an increased risk of fractures. (2017-10-11)
Study highlights underlying mechanisms of fractures associated with osteoporosis drug
There is no disputing that the use of bisphosphonates -- with brand names such as Fosamax, Boniva and Reclast -- is proven to combat bone loss and fragility fractures in millions of osteoporosis patients for whom a fracture could be debilitating, even life-threatening. (2017-07-31)
Quantifying lower limb muscle weakness in Osteogenesis Imperfecta type IV
To date, muscle function, and in particular that of the lower extremity, in OI type IV has not been investigated systematically. (2017-07-26)
Promising new therapeutic approach for debilitating bone disease
Australian researchers have demonstrated that a new type of therapeutic could greatly reduce bone disease in patients with the bone cancer, multiple myeloma. (2017-06-29)
Specific long-term therapy may not prevent fractures in older women
Bisphosphonates are sometimes used to treat osteoporosis. Studies have shown that the risk for bone fractures lessens when women with low bone mineral density take these medications for between one and four years. (2017-06-02)
Mutation discovered that, linked with drug, predisposes osteoporosis patients to femur fracture
Bisphosphonates are the first line of fracture prevention treatment in osteoporosis. (2017-05-04)
Study finds worse survival when specific thyroid cancers spread to bone
In the largest-known study on bone metastases in thyroid cancer, researchers at the University of Michigan Comprehensive Cancer Center found that patients with follicular and medullary thyroid cancer had the highest rate of cancer-related bone lesions and fractures and an increased risk of death. (2017-04-14)
Benefits and harms of osteoporosis medications unclear for patients with CKD
More research is needed to determine the benefits and harms of osteoporosis medications on bone mineral density, fracture risk, and safety among patients with chronic kidney disease (CKD). (2017-04-10)
Making bones stronger
New treatments for osteoporosis are desperately needed. Two University of Delaware scientists report estimates of potentially the most effective dosage of a particular peptide, with results that could raise density levels in badly degraded bones back to healthy levels. (2017-03-29)
Drug used to treat weak bones associated with micro-cracks
A type of drug used to treat weak bones is associated with an increased risk of 'micro-cracks' in bone, according to new research. (2017-03-03)
Study provides insights on optimal treatment of Paget's disease of bone
In a study of patients with Paget's disease of bone--a common skeletal disorder that can lead to bone deformity, fractures, osteoarthritis, and bone pain -- long-term intensive bisphosphonate therapy conferred no clinical benefit over giving bisphosphonates only when patients felt bone pain. (2017-02-08)
Bone markers as screening strategy for patient adherence to osteoporosis medications
This IOF and ECTS Working Group position paper proposes measuring specific bone turnover markers (BTMs) in patients who have initiated use of oral bisphosphonates for postmenopausal osteoporosis as a practical way to identify low adherence. (2017-01-30)
Study examines the effects of osteoporosis drugs in children with genetic bone disorders
Previous case reports in patients with osteogenesis imperfecta (OI) have suggested that treatment with bisphosphonates, which are commonly prescribed for osteoporosis, may be associated with atypical femur fractures. (2017-01-09)
Study finds one-third of women taking bisphosphonates remain at risk for fracture
A recent study of oral bisphosphonates, the most commonly prescribed osteoporosis treatment, found that approximately a third of women prescribed these drugs continue to be at elevated risk for bone fracture, an outcome that may have several origins. (2016-06-06)
Expert panel evaluates role of osteoporosis medications in fracture healing
Using a structured expert-opinion process, an International Osteoporosis Foundation expert panel has written a consensus report on the use of osteoporosis medications in patients with recent fracture and the potential role of these medications in promoting fracture healing. (2016-04-27)
Herbert A. Fleisch ESCEO-IOF Medal 2016 awarded to Professor René Rizzoli
Professor René Rizzoli, Emeritus Professor of Medicine at University Hospitals of Geneva has been awarded the prestigious Herbert A. (2016-04-14)
To treat a leading cause of osteoporosis, surgery is better than widely used medications
A leading cause of the bone-loss disease osteoporosis is hyperparathyroidism. (2016-04-04)
Surgery associated with reduced fractures in patients with hyperparathyroidism
Surgery to remove the parathyroid was associated with reduced fracture risk in patients with primary hyperparathyroidism, whereas bisphosphonate treatment was associated with increased bone mineral density but not fewer fractures. (2016-04-04)
Drugs that treat osteoporosis also can cause small risk of thigh bone fractures
Osteoporosis drugs have significantly reduced the risk of bone fractures for millions of people, but also have been linked to unusual fractures of the femur (thigh bone). (2016-02-29)
Task force provides guidance on use of osteoporosis drugs
A new report by a task force of the American Society for Bone and Mineral Research provides guidance on the use of bisphosphonates, which are the most commonly used medications for osteoporosis. (2016-01-19)
Page 1 of 6 | 202 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.